Literature DB >> 16652410

Applications of functional magnetic resonance imaging in psychiatry.

Martina T Mitterschiffthaler1, Ulrich Ettinger, Mitul A Mehta, David Mataix-Cols, Steve C R Williams.   

Abstract

While the use of MRI techniques has become a cornerstone of the neurology clinic, the application of such methods in psychiatry was rather limited until the advent of functional magnetic resonance imaging (fMRI). Over the past decade fMRI has superseded radionuclide-imaging techniques and blossomed into a widely used psychiatric research tool. This review focuses on the neurobiological findings from fMRI research in three less well-documented psychiatric disorders: attention deficit hyperactivity disorder (ADHD), depression, and obsessive-compulsive disorder (OCD). Although there was some disparity in early findings, greater standardization of image acquisition, analysis, and paradigms, and improved clinical classification are leading to a greater convergence of observations from different laboratories. fMRI is also beginning to realize its potential as an important mediator between genes and phenotypes, and may thus contribute to a better understanding of the pathophysiology of major neuropsychiatric diseases. The role of fMRI in the objective assessment of therapeutic intervention and early prediction of response to treatment is also discussed. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16652410     DOI: 10.1002/jmri.20590

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  9 in total

1.  PET and SPECT in psychiatry: the past and the future.

Authors:  Marco Pagani; Sara Carletto; Luca Ostacoli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09       Impact factor: 9.236

2.  Functional magnetic resonance imaging of internet addiction in young adults.

Authors:  Gianna Sepede; Margherita Tavino; Rita Santacroce; Federica Fiori; Rosa Maria Salerno; Massimo Di Giannantonio
Journal:  World J Radiol       Date:  2016-02-28

3.  Reproducibility of activation maps for longitudinal studies of visual function by functional magnetic resonance imaging.

Authors:  Jing Ming; Keith R Thulborn; Janet P Szlyk
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-14       Impact factor: 4.799

4.  Neurological subtle signs and cognitive development: a study in late childhood and adolescence.

Authors:  Isabel Pavão Martins; Martin Lauterbach; Henrique Luís; Helena Amaral; Gail Rosenbaum; Peter D Slade; Brenda D Townes
Journal:  Child Neuropsychol       Date:  2012-06-14       Impact factor: 2.500

5.  5-HTT genotype effect on prefrontal-amygdala coupling differs between major depression and controls.

Authors:  Eva Friedel; Florian Schlagenhauf; Philipp Sterzer; Soyoung Q Park; Felix Bermpohl; Andreas Ströhle; Meline Stoy; Imke Puls; Claudia Hägele; Jana Wrase; Christian Büchel; Andreas Heinz
Journal:  Psychopharmacology (Berl)       Date:  2009-04-23       Impact factor: 4.530

6.  In the mind's eye: provider and patient attitudes on functional brain imaging.

Authors:  J Illes; S Lombera; J Rosenberg; B Arnow
Journal:  J Psychiatr Res       Date:  2008-12       Impact factor: 4.791

7.  Effects of taurine on resting-state fMRI activity in spontaneously hypertensive rats.

Authors:  Vincent Chin-Hung Chen; Tsai-Ching Hsu; Li-Jeng Chen; Hong-Chun Chou; Jun-Cheng Weng; Bor-Show Tzang
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

8.  Two distinct profiles of fMRI and neurophysiological activity elicited by acetylcholine in visual cortex.

Authors:  Daniel Zaldivar; Alexander Rauch; Nikos K Logothetis; Jozien Goense
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-03       Impact factor: 11.205

9.  Sub-graph entropy based network approaches for classifying adolescent obsessive-compulsive disorder from resting-state functional MRI.

Authors:  Bhaskar Sen; Gail A Bernstein; Bryon A Mueller; Kathryn R Cullen; Keshab K Parhi
Journal:  Neuroimage Clin       Date:  2020-02-06       Impact factor: 4.881

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.